Clinical Trial Update: Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating whether omega-3 fatty acids reduce methotrexate-induced hepatotoxicity in children with acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Nancy Samir Elbarbary | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED